期刊
CARDIOLOGY IN REVIEW
卷 28, 期 3, 页码 140-147出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/CRD.0000000000000291
关键词
myocardial infarction; regeneration; stem cells
Each year 790,000 people in the United States suffer from a myocardial infarction. This results in the permanent loss of cardiomyocytes and an irreversible loss of cardiac function. Current therapies lower mortality rates, but do not address the core pathology, which opens a pathway to step-wise heart failure. Utilizing stem cells to regenerate the dead tissue is a potential method to reverse these devastating effects. Several clinical trials have already demonstrated the safety of stem cell therapy. In this review, we highlight clinical trials, which have utilized various stem cell lineages, and discuss areas for future research.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据